Novel HIV drugs and drug delivery strategies. A report from the 2018 Conference on Retroviruses and Opportunistic Infections. Boston, Massachusetts, USA - March 4-7, 2018
The 2018 Conference on Retroviruses and Opportunistic Infections (CROI 2018) was held from March 4 to March 7, 2018, in Boston, Massachusetts. Important research on all aspects of HIV was presented and discussed. This report focuses on new drugs that were presented at CROI 2018, including drugs for the reversal of latency and monoclonal antibodies. Presentations on new drug delivery strategies, such as nanoformulations, intradermal implants and topical formulations are also reviewed..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2018 |
---|---|
Erschienen: |
2018 |
Enthalten in: |
Zur Gesamtaufnahme - volume:043 |
---|---|
Enthalten in: |
Drugs of the future - 043(2018), 4, Seite 0283 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Rizza,US!aS.A. [VerfasserIn] |
---|
Links: |
---|
BKL: |
---|
doi: |
10.1358/dof.2018.043.04.2809259 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
OLC200050020X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | OLC200050020X | ||
003 | DE-627 | ||
005 | 20230516073303.0 | ||
007 | cr uuu---uuuuu | ||
008 | 180809s2018 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1358/dof.2018.043.04.2809259 |2 doi | |
028 | 5 | 2 | |a fidpha__2018-08-09.pp |
035 | |a (DE-627)OLC200050020X | ||
035 | |a (DE-599)GBVOLC200050020X | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |
084 | |a PHARM |2 fid | ||
084 | |a 44.40 |2 bkl | ||
100 | 1 | |a Rizza,US!aS.A. |e verfasserin |4 aut | |
245 | 1 | 0 | |a Novel HIV drugs and drug delivery strategies. A report from the 2018 Conference on Retroviruses and Opportunistic Infections. Boston, Massachusetts, USA - March 4-7, 2018 |
264 | 1 | |c 2018 | |
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a The 2018 Conference on Retroviruses and Opportunistic Infections (CROI 2018) was held from March 4 to March 7, 2018, in Boston, Massachusetts. Important research on all aspects of HIV was presented and discussed. This report focuses on new drugs that were presented at CROI 2018, including drugs for the reversal of latency and monoclonal antibodies. Presentations on new drug delivery strategies, such as nanoformulations, intradermal implants and topical formulations are also reviewed. | ||
700 | 1 | |a Bhatia,US!aR. |e verfasserin |4 aut | |
700 | 1 | |a Temesgen,US!aZ. |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Drugs of the future |d Barcelona : Prous Science - Thomson Reuters, 1976 |g 043(2018), 4, Seite 0283 |w (DE-627)13048489X |w (DE-600)752959-4 |w (DE-576)016071395 |x 0377-8282 |7 nnns |
773 | 1 | 8 | |g volume:043 |g year:2018 |g number:4 |g pages:0283 |
856 | 4 | 0 | |u https://doi.org/10.1358/dof.2018.043.04.2809259 |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a FID-PHARM | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OLC-DE-84 | ||
912 | |a SSG-OPC-PHA | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_4125 | ||
936 | b | k | |a 44.40 |q AVZ |
951 | |a AR | ||
952 | |d 043 |j 2018 |e 4 |h 0283 |